Charles A. Reinhart, III
2020
In 2020, Charles A. Reinhart, III earned a total compensation of $2M as Chief Financial Officer at Pacira Pharmaceuticals, a 45% increase compared to previous year.
Compensation breakdown
| Bonus | $223,500 |
|---|---|
| Option Awards | $706,355 |
| Salary | $463,692 |
| Stock Awards | $600,390 |
| Other | $15,168 |
| Total | $2,009,105 |
Reinhart received $706.4K in option awards, accounting for 35% of the total pay in 2020.
Reinhart also received $223.5K in bonus, $463.7K in salary, $600.4K in stock awards and $15.2K in other compensation.
Rankings
In 2020, Charles A. Reinhart, III's compensation ranked 5,491st out of 13,090 executives tracked by ExecPay. In other words, Reinhart earned more than 58.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,491 out of 13,090 | 58th |
Division Manufacturing | 2,259 out of 5,620 | 60th |
Major group Chemicals And Allied Products | 902 out of 2,253 | 60th |
Industry group Drugs | 779 out of 1,953 | 60th |
Industry Pharmaceutical Preparations | 581 out of 1,458 | 60th |
Source: SEC filing on April 22, 2022.
Reinhart's colleagues
We found three more compensation records of executives who worked with Charles A. Reinhart, III at Pacira Pharmaceuticals in 2020.